Skip to main content
. 2020 Mar 23;75(5):341–347. doi: 10.1016/j.crad.2020.03.004

Table 2.

Chest CT imaging manifestations

Lesion location
Peripheral zone 48 (43.6%)
Central zone 0 (0%)
Both 62 (56.4%)
Lesion distribution
Single lobe of one lung 10 (9.1%)
Multiple lobes of one lung 6 (5.5%)
Multiple lobes of both lungs 80 (72.7%)
Bilateral lower lungs 4 (3.6%)
Bilateral middle and lower lungs 10 (9.1%)
Lesion morphology
Patchy 56 (50.1%)
Spherical 28 (25.5%)
Both 26 (14.5%)
Lesion density
Ground-glass opacity 30 (27.3%)
Consolidation 30 (27.3%)
Both 50 (45.4%)
Lesion staging
Early stage 30 (27.3%)
Progressing stage 54 (49.1%)
Sever stage 26 (23.6%)
Other changes
Pleural effusion 1 (0.9%)
No abnormality in lung 3 (2.6%)
Follow-up
No change 0 (0%)
Lesion disappeared 0 (0%)
Lesion mitigated slightly 4 (25%)
Mild disease progression 7 (43.8%)
Moderate disease progression 5 (31.2%)
Severe disease progression 0 (0%)